Erdafitinib is a medicine that helps with metastatic urothelial carcinoma. It specifically targets FGFR2/3 alterations. It works by stopping FGFR signaling.
You can get this drug in tablets that come in 3 mg, 4 mg, and 5 mg strengths. They usually suggest taking 8 mg a day, but it might go up to 9 mg. The medicine comes in bottles, each containing 56 tablets.
